Open Access
Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysis
Journal Of The Chinese Medical AssociationNing-Tao Wang +52016Journals
Antituberculosis drug-induced liver injury (ATDILI) is a major safety concern for the treatment of tuberculosis (TB). The impact of chronic hepatitis B infection (CHBI) on the risk of ATDILI is still controversial. In this study, we aimed to assess systematically the influence of CHBI on the susceptibility to ATDILI.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support